Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-28
1990-03-20
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514273, 514825, 514826, 514863, 514925, 544320, 544321, A61K 31505, A61K 31445, C07D23922
Patent
active
049102044
ABSTRACT:
A compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is hydrogen; R.sup.2 is (C.sub.1 -C.sub.15) alkyl, (C.sub.3 -C.sub.15)alkenyl, phenyl, substituted phenyl, (C.sub.7 -C.sub.20)-phenylalkyl, or substituted (C.sub.7 -C.sub.20)phenylalkyl wherein the substituents on the substituted phenyl and substituted phenylalkyl are independently one or two of fluoro, chloro, (C.sub.1 -C.sub.3)alkyl, (C.sub.1 -C.sub.3 alkoxy, and trifluoromethyl; or R.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached form a pyrrolodinyl, substituted pyrrolidinyl, piperidyl or substituted piperidyl group, wherein the substituents on said substituted pyrrolidinyl and piperidyl groups are independently one of (C.sub.1 -C.sub.6)alkyl, phenyl, and (C.sub.7 -C.sub.9)phenylalkyl; and R.sup.3 is hydrogen, (C.sub.1 -C.sub.6)alkyl, phenyl, substituted phenyl, (C.sub.7 -C.sub.9)phenylalkyl, or substituted (C.sub.7 -C.sub.9)phenylalkyl, wherein the substituents on the substituted phenyl and substituted phenylalkyl are independently one or two of fluoro, chloro, (C.sub.1 -C.sub.3)alkyl, (C.sub.1 -C.sub.3)alkoxy, and trifluoromethyl.
The compounds are useful in treating inflammation or other leukotriene mediated diseases, including plumonary, asthmatic, allergic, and gastrointestinal diseases.
REFERENCES:
patent: 4153793 (1979-05-01), Durant et al.
patent: 4416885 (1983-11-01), Huve
patent: 4535080 (1985-08-01), Audiau et al.
patent: 4554276 (1985-11-01), LaMiattina
patent: 4694008 (1987-09-01), Brown et al.
Lazarev et al, CA 67-72356b (1967) "Effect of some pyrimidine derivatives on the blastomogenis . . . ".
Asadov, CA 70-2232w (1969) "Effect of 4-methylisocytosine and 5-hydroxy-4-methyisocytosine . . . ".
Miller et al. CA 78-54733v (1973) "Guanine phosphoribosyltransferase from Escherichia coli.".
Oda et al, CA 79-66309v (1973) "Synthesis of compounds related to antitumor agents. I".
Plechev. CA 80-22502u (1974) "Stimulation with some pyrimidine derivatives of . . . ".
Plechov CA 85-116661a (1976) "Stimulation of the absorbent capacity of . . . ".
Plechev, CA 87-127456e (1977) "Effect of some pyrimidine deriviatives on the . . . ".
Wierenpa et al, CA 95-43025r (1981) "Synthesis of 2-amino-6-phenyl-4(3H)-pyrimidinone-1-oxide".
Sako et al, CA 102-6373v (1985) "A versatile and convenient method for the synthesis .. . ".
LaMattina, Tetrahedron Letters, vol. 24, No. 20, pp. 2059-2062 (1988).
Jakschick, Prostaglandins, vol. 16, No. 5, pp. 733-747 (1978).
Hull, J. Chem. Soc., pp. 2033-2035 (1956).
LaMattina, Tetrahedron, vol. 44, No. 11, pp. 3073-3078 (1988).
Lasarev et al., Vop. Onkol, 13(7), 56-9 (1967).
Perchonock et al., Drugs of the Future, 12(9), 871-889 (1987).
Payne, Brit. Med. Journal, 295, 1138-1140 (1987).
Dale, Textbook of Immunopharmacology, 137-139 (1984).
LaMattina John L.
O'Neill Brian T.
Walker Frederick J.
DeBenedictis Karen
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Shen Cecilia
LandOfFree
2-amino-5-hydroxy-4-pyrimidones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-amino-5-hydroxy-4-pyrimidones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino-5-hydroxy-4-pyrimidones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793078